CD4 and Parkinson disease: HMGB1 A box, a competitive inhibitor protein of HMGB1, which has been proved to aggravate the inflammatory response in PD, inhibits the Th17 ratio in CD4+ T cells and T cells infiltration in MPP+-induced animal model via modulating CD200-CD200R signal pathway [173].